PT Esa Medika Mandiri Tbk Income Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	504,586	454,636	384,935	172,981
Revenue Growth	-	18.11%	122.53%	-
Cost of Revenue	323,126	291,848	250,018	84,881
Gross Profit	181,460	162,788	134,917	88,100
Selling, General & Admin	102,713	95,947	94,317	78,946
Operating Expenses	102,713	95,947	94,317	78,946
Operating Income	78,747	66,841	40,599	9,154
Interest Expense	-26,239	-30,439	-29,513	-22,633
Earnings From Equity Investments	4,101	4,101	1,626	-
Currency Exchange Gain (Loss)	-159.38	-387.79	-378.35	-95.59
Other Non Operating Income (Expenses)	2,146	2,975	1,502	14,408
Pretax Income	58,595	43,090	13,836	833.23
Income Tax Expense	10,650	10,650	2,581	-106.19
Earnings From Continuing Operations	47,945	32,440	11,255	939.42
Minority Interest in Earnings	3,358	1,692	-246.23	-
Net Income	51,303	34,132	11,009	939.42
Net Income to Common	51,303	34,132	11,009	939.42
Net Income Growth	-	210.05%	1071.86%	-
Shares Outstanding (Basic)	1,220	1,220	1,220	1,220
Shares Outstanding (Diluted)	1,220	1,220	1,220	1,220
Shares Change	-	-	-	-
EPS (Basic)	42.05	27.98	9.02	0.77
EPS (Diluted)	42.05	27.98	9.02	0.77
EPS Growth	-	210.05%	1071.86%	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	23,540	-34,113	51,215	-93,942
Free Cash Flow Per Share	19.30	-27.96	41.98	-77.00
Gross Margin	35.96%	35.81%	35.05%	50.93%
Operating Margin	15.61%	14.70%	10.55%	5.29%
Profit Margin	10.17%	7.51%	2.86%	0.54%
Free Cash Flow Margin	4.67%	-7.50%	13.30%	-54.31%
EBITDA	97,127	84,232	58,868	25,561
EBITDA Margin	19.25%	18.53%	15.29%	14.78%
D&A For EBITDA	18,380	17,391	18,269	16,407
EBIT	78,747	66,841	40,599	9,154
EBIT Margin	15.61%	14.70%	10.55%	5.29%
Effective Tax Rate	18.18%	24.72%	18.65%	-